Insider buying last 90 days
No open-market insider purchases were filed for RJF in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
This week's news flow around Raymond James centers on its research arm's activity rather than the firm's own results. The company issued several rating actions on other names, including a downgrade of Aardvark Therapeutics to Market Perform from Strong Buy on FDA path concerns, a reiterated Market Perform on Dine Brands after an earnings miss, a reiterated Strong Buy and $135.00 target on Wayfair following a third-quarter beat, a reiterated Outperform and $120 target on CVS Health ahead of its earnings, a reiterated Underperform on Graphic Packaging despite encouraging third-quarter results, and a reported downgrade of DR Horton to Underperform tied to a fourth-quarter earnings miss and valuation concerns. Separately, Raymond James and LPL Financial recruited advisor teams in Ohio and Pennsylvania, and the firm is supporting a $15,000 matching gift campaign for Operation Healing Forces.
RJF closed at $168.69, up 4.3%, sitting above both its 50-day average of $163.93 and 200-day average of $160.03, with the 50-day above the 200-day. The GekkoIndex reads 49.8, placing the stock in the Neutral zone after a five-point change of -12.1. Shares trade 1.5% below the Gekko Fair Value of $171.31.
Over the next 20 trading days, the next earnings report falls on 27 January 2027, 83 days out, beyond this window. No insider, Congress or unusual options activity appears in their respective tracking periods. Seasonally, the stock has averaged a 2.3% gain over this stretch across 5 years, rising in 3 of them.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Raymond James Financial scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $168.69 is above the 50-day ($163.93) and 200-day ($160.03) averages, and the 50-day is above the 200-day.
See the chart49.8, Neutral
Reading 49.8 is in the Neutral zone.
See the GekkoIndex1.5% below
Price is within 5% of Gekko Fair Value (1.5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 83 days
Next report Jan 27, 2027, 83 days away — outside a typical 20-trading-day hold.
See earnings+2.3% on average
From this point in the calendar, the next 20 trading days averaged +2.3% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Raymond James Financial closed at $168.69 on Nov 4, 2026, +6.2% over the past year, inside a 52-week range of $138.82 to $182.73.
Use the left and right arrow keys to read daily values.
Put RJF on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Raymond James Financial provides financial services to individuals, companies, and public sector clients across the United States, Canada, and Europe. It is widely recognized for its Private Client Group, which offers investment guidance, tailored portfolio management, insurance and annuity products, and mutual funds, along with margin lending and securities borrowing and lending arrangements.
The firm's work is divided into several segments. Capital Markets handles investment banking work such as equity and debt offerings and merger and acquisition advice, plus brokerage services in fixed income and equities. Asset Management serves both retail and institutional clients with portfolio management and administrative support like record-keeping. Raymond James Bank offers insured deposits and lending products, including commercial and industrial loans, commercial real estate and construction financing, tax-exempt loans, residential mortgages, and securities-based loans, along with loan syndication. A separate Other segment covers private equity activity, including direct investments, third-party fund investments, and legacy portfolio management.
Founded in 1962, Raymond James Financial is headquartered in St. Petersburg, Florida. Its shares are listed on the NYSE under the ticker RJF.
Raymond James Financial’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 49.8, in the Neutral zone, down 12.1 points over five sessions.
Down 12.1 points over five sessions, from the Accumulation zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 21 | +2.5% | +2.1% | ||
| Accumulation | 208 | −0.1% | +0.2% | ||
| Neutral (current zone) | 420 | +0.3% | +1.2% | ||
| Distribution | 45 | +1.0% | +6.4% | ||
| Selling | 3 | Too few readings yet | |||
Average RJF share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Raymond James Financial trades 1.5% below Gekko Fair Value of $171.31, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Raymond James Financial shares are worth, recalculated every trading day.
$171.31
Gekko Fair Value, Nov 4, 2026
1.5% below fair value · About fair value
At the end of Aug 2026 the price was 1.3% below the estimate.
No open-market insider purchases were filed for Raymond James Financial, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for RJF in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in RJF were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Raymond James Financial has been buying back its own shares.
From company filings.
Raymond James Financial reports on Jan 27, 2027 (83 days away).
Jan 27, 2027
83 days away
Analysts’ average 12-month price target for Raymond James Financial is $182.21, +8.0% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 29 | Barclays | $197 | +16.8% |
| Oct 29 | Wells Fargo | $169 | +0.2% |
| Oct 29 | Bank of America Securities | — | — |
| Oct 29 | TD Cowen | $160 | −5.2% |
| Oct 28 | BMO Capital | $170 | +0.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Raymond James Financial averaged +2.3% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.5% | 4 of 5 |
| Next 10 trading days | +2.5% | 3 of 5 |
| Next 15 trading days | +2.2% | 2 of 5 |
| Next 20 trading days | +2.3% | 3 of 5 |
| Next 30 trading days | +0.9% | 3 of 5 |
For scale, RJF’s typical 20-trading-day move in either direction is about 5.8%.
Raymond James Financial’s market cap is $32.41B, with a P/E ratio of 13.6 and revenue of $15.82B over the last twelve months.
Coverage of Raymond James Financial this week reads positive: 16 positive, 8 neutral and 1 negative headlines.
Raymond James Financial’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSMorgan Stanley | Neutral | 4.3% below |
| BLKBlackRock | Neutral | 1.5% above |
| UBSUBS | Neutral | 2.7% below |
| BXBlackstone | Neutral | 2.3% below |
| BNBrookfield | Distribution | 3.0% below |
| KKRKKR | Neutral | 4.6% below |
A peer links to its own page where one exists.
Raymond James Financial’s market cap is $32.41B at the Nov 4, 2026 close of $168.69, with 192.1M shares outstanding. The shares trade on a P/E ratio of 13.6.
The consensus analyst 12-month price target for Raymond James Financial is $182.21, +8.0% from the last close. Of the 10 firms that rated the stock in the last 90 days, 2 rate it a buy, 8 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Raymond James Financial is about fair value: the Nov 4, 2026 close of $168.69 is 1.5% below Gekko Fair Value of $171.31. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Raymond James Financial is expected to report on Jan 27, 2027 (83 days away). Analysts expect earnings of $3.30 per share on revenue of $4.21B.
Raymond James Financial’s 52-week high is $182.73 and its 52-week low is $138.82; it closed at $168.69 on Nov 4, 2026, +6.2% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.